Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Richard L. Proia, Timothy Hla
Richard L. Proia, Timothy Hla
Published April 1, 2015
Citation Information: J Clin Invest. 2015;125(4):1379-1387. https://doi.org/10.1172/JCI76369.
View: Text | PDF
Review Article has an altmetric score of 14

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy

  • Text
  • PDF
Abstract

Membrane sphingolipids are metabolized to sphingosine-1-phosphate (S1P), a bioactive lipid mediator that regulates many processes in vertebrate development, physiology, and pathology. Once exported out of cells by cell-specific transporters, chaperone-bound S1P is spatially compartmentalized in the circulatory system. Extracellular S1P interacts with five GPCRs that are widely expressed and transduce intracellular signals to regulate cellular behavior, such as migration, adhesion, survival, and proliferation. While many organ systems are affected, S1P signaling is essential for vascular development, neurogenesis, and lymphocyte trafficking. Recently, a pharmacological S1P receptor antagonist has won approval to control autoimmune neuroinflammation in multiple sclerosis. The availability of pharmacological tools as well as mouse genetic models has revealed several physiological actions of S1P and begun to shed light on its pathological roles. The unique mode of signaling of this lysophospholipid mediator is providing novel opportunities for therapeutic intervention, with possibilities to target not only GPCRs but also transporters, metabolic enzymes, and chaperones.

Authors

Richard L. Proia, Timothy Hla

×

Figure 3

Functions of S1P in vascular development and hematopoietic cell trafficking.

Options: View larger image (or click on image) Download as PowerPoint
Functions of S1P in vascular development and hematopoietic cell traffick...
(A) During embryogenesis, rbc-derived S1P plays an essential role in the stabilization of the developing vascular system. In the postnatal period, both rbc and the endothelium release S1P into circulation to maintain vascular homeostasis. Plasma S1P is associated with ApoM+ HDL and albumin. S1P signaling regulates blood flow, endothelial integrity, barrier function, and antiinflammatory functions. (B) There is a steep S1P gradient between vascular and extravascular compartments. This is essential for trafficking of T cells from thymus and secondary lymphoid organs into blood and lymph, respectively. In the bone marrow sinusoids, S1P signaling is important for the release of megakaryocyte proplatelet extensions into the circulation.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 18 X users
Referenced in 1 patents
On 2 Facebook pages
Mentioned in 1 Google+ posts
304 readers on Mendeley
See more details